Rapid Human Immunodeficiency Virus Decay in Highly Active Antiretroviral Therapy (HAART)-Experienced Children after Starting Mega-HAART
- 15 October 2004
- journal article
- clinical trial
- Published by American Society for Microbiology in Journal of Virology
- Vol. 78 (20), 11272-11275
- https://doi.org/10.1128/jvi.78.20.11272-11275.2004
Abstract
Increasing numbers of patients are treated with mega-highly active antiretroviral therapy (HAART), or multiple-combination antiretroviral therapy, in an attempt to overcome the viral resistance that has contributed to treatment failure. Studies of human immunodeficiency virus (HIV) viral dynamics are used to quantify the potency of a given regimen. While mega-HAART is expected to provide potent therapy, its potency among heavily experienced HIV-infected children who have failed previous treatment is untested. HIV dynamics studies performed in children have provided minimal information on viral dynamics during mega-HAART. The present study estimates first- and second-phase viral dynamics in six children on mega-HAART, following failure of combination therapy. The first phase of viral decay was rapid, relative to rates reported in previous pediatric studies (median δ = 0.778 d − 1 , range = 0.583 to 1.088, half-life 1 [ t 1 1/2 ] = 0.894 d ), while the second phase revealed results similar to those of previous studies (median μ = 0.026 d − 1 , range = −0.005 to 0.206, t 2 1/2 = 9.316d). This indicates that mega-HAART can provide potent therapy among heavily experienced pediatric patients.Keywords
This publication has 13 references indexed in Scilit:
- Multiple drug rescue therapy for HIV-infected individuals with prior virologic failure to multiple regimensAIDS, 2001
- A Comparison Study of Models and Fitting Procedures for Biphasic Viral Dynamics in HIV‐1 Infected Patients Treated with Antiviral TherapiesBiometrics, 2000
- Relationships between antiviral treatment effects and biphasic viral decay rates in modeling HIV dynamicsMathematical Biosciences, 1999
- Population HIV‐1 Dynamics In Vivo: Applicable Models and Inferential Tools for Virological Data from AIDS Clinical TrialsBiometrics, 1999
- Characterization of Viral Dynamics in Human Immunodeficiency Virus Type 1–Infected Patients Treated with Combination Antiretroviral Therapy: Relationships to Host Factors, Cellular Restoration, and Virologic End PointsThe Journal of Infectious Diseases, 1999
- HIV-1 Dynamics in ChildrenJAIDS Journal of Acquired Immune Deficiency Syndromes, 1999
- Antiretroviral Drug Resistance Testing in Adults With HIV InfectionJAMA, 1998
- Decay characteristics of HIV-1-infected compartments during combination therapyNature, 1997
- Viral dynamics in vivo: limitations on estimates of intracellular delay and virus decay.Proceedings of the National Academy of Sciences, 1996
- HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation TimeScience, 1996